ISPOR - EE153 Cost From Asparaginase Utilization in the Treatment of Acute Lymphoblastic Leukaemia in Hong Kong Paediatrics Population According to CCCG-2015 Protocol

EE153 Cost From Asparaginase Utilization in the Treatment of Acute Lymphoblastic Leukaemia in Hong Kong Paediatrics Population According to CCCG-2015 Protocol

Abstract

Authors

JTS Li CK Li F Cheng V Lee

Full Text Cite This Article

Back to Volume 25, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now